Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer

Overview of attention for article published in Frontiers in endocrinology, July 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy: 1 policy source

twitter: 3 X users

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,184 followers.

RT @RevistaEndoMex: Nuevas terapias en #cancer #cancerdetiroides #tiroides refractario a yodo radioactivo. https://t.co/qjrJpBBJ8r

17 Jul 2021

Reply Repost Favourite

Nuevas terapias en #cancer #cancerdetiroides #tiroides refractario a yodo radioactivo. https://t.co/qjrJpBBJ8r

15 Jul 2021

Reply Repost Favourite

New Research: Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer: Iodine-resistant cancers account for the vast majority of thyroid related mortality and, until recently, there were limited therapeutic options.… https://t.co/WT2EHpnYKR #Endo

15 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.